The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ICML 2023 | The possibility of moving away from radiation therapy in pediatric patients with Hodgkin lymphoma
Mark Roschewski, MD, National Cancer Institute, Bethesda, MD, discusses the changing role of radiation therapy (RT) in Hodgkin lymphoma (HL), explaining that RT is still frequently used in pediatric patients. Dr Roschewski further explains the importance of moving away from RT in this patient population to avoid complications later on. This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
